跳至主要内容
临床试验/NL-OMON56175
NL-OMON56175已完成不适用

esion Characteristics after Pulsed-Field Ablation in Patients with Atrial Fibrillation and a Left Common Ostium (PFALCO RE-MAP STUDY) - PFALCO Re-map study

OLVG0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Age > 18 years of age on the day of enrolment of either sex
  • - Willing to sign informed consent
  • - Left atrial volume index measured < 60 ml/m2 within last 12 months
  • - Documented atrial fibrillation
  • - Admitted and accepted for PVI
  • - A left common ostium of the pulmonary veins identified by CT or MRI
  • - Accepted to receive general anaesthesia

排除标准

  • - Patients age < 18
  • - Body mass index > 35kg/m2
  • - Left atrial volume index >= 60 ml/m2 within 12 months on MRI or cardiac echo
  • - New York Heart Association heart failure class III or IV
  • - Myocardial infarction within three months before the procedure
  • - Unstable angina pectoris
  • - Percutaneous coronary interventions within three months before the procedure
  • - Sudden cardiac death event within three months before the procedure
  • - Life expectancy of less than one year
  • - Presence of an atrial tachycardia other than cavotricuspid isthmus dependent
  • atrial flutter
  • - History of blood clotting or bleeding abnormalities
  • - History of a thromboembolic event within six months before the procedure
  • - A contraindication to anticoagulant
  • - Clinical significant infection
  • - Unstable clinical significant medical condition
  • - Previous left atrium ablation, except successful accessory pathway ablation
  • - Presence of a left appendage closure device
  • - Presence of an atrial septum occluder
  • - Presence of a prosthetic heart valve
  • - Occlusion of the inferior venous tract
  • - Enrolment in another study that would interfere with this study

研究者

发起方
OLVG

相似试验